Abstract
OBJECTIVE: Peroxisome-proliferator-activated receptors γ (PPAR γ), is a key regulator of adipocyte differentiation and energy balance. Two naturally occurring mutations in the PPAR γ gene, Pro115Gln and Pro12Ala, have recently been shown to impair the function of the PPARγ2 isoform of the receptor and to be associated with obesity or diabetes- related phenotypes in different populations.
SUBJECTS: We studied the occurrence and possible associations of the Pro115Gln and Pro12Ala in the PPAR γ2 gene with several clinical and metabolic phenotypes in three independent large populations of non-obese non-diabetic, type 2 diabetic, and morbidly obese French Caucasians.
RESULTS: The Pro115Gln mutation was not found in any of the 1069 subjects screened including 626 obese patients. The frequency of the Pro12Ala mutation was similar in all groups (0.08, 0.11,0.09) and was not associated with BMI or any of the clinical parameters tested.
CONCLUSIONS: We conclude that the Pro115Gln mutation is not a frequent cause of morbid obesity in Caucasians and that the Pro12Ala mutation is not associated with clinically significant changes in these populations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Spiegelman B . PPARγ: a adipogenic regulator and thiazolinedione receptor Diabetes 1998 47:: 507–513.
Lehmann J, Morre L, Smith-Olivier T, Wilkison W, Wilson T, Kliewer S . An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ Bio Chem 1995 270:: 12953–12956.
Forman B, Tontonoz P, Chen J, Brun R, Spiegelman B, Evans R . 15-Deoxy-Δ12,14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ Cell 1995 83:: 803–812.
Vidal-Puig A, Considine R, Jimenez-Linan M, Werman A, Pories W, Caro J, Flier J . Peroxisome proliferator-activated receptort gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997 99:: 2416–2422.
Spiegelman B, Flier J . Adipogenesis: rounding out the big picture Cell 1996 87:: 377–389.
Latruffe N, Vamecq J . Peroxisome proliferator activated receptor (PPARs) as regulators of lipid metabolism Biochimie 1997 79:: 81–94.
Bloomgarden Z . Insulin resistance: current concepts Clin Ther 1998 20 (2): 216–231.
Neel J, Weder A, Julius S . Type II diabetes, essential hypertension, and obesity as “syndromes of impaired genetic homeostasis”: the “thrifty genotype” hypothesis enters the 21st century Perspect Biol Med 1998 42 (1): 44–74.
Deeb S, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J . A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nature Genet 1998 20:: 284–287.
Ristow M, Muller-Wieland D, Pfeiffer A, Kahn C . Obesity associated with a mutation in a genetic regulator of adipocyte differentiation N Engl J Med. 1998 339 (14): 953–959.
Yen C, Beamer B, Negri C, Silver K, Brown K, Yarnall D, Burns D, Roth J, Shuldiner A . Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPAR γ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation Biochem Biophys Res Commun 1997 24 (2):: 270–274.
Mori Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer B, Shuldiner A, Akanuma Y, Yasaki Y, Kadowaki T . Effect of the Pro12Ala variant of the human peroxisome proliferator activated receptor γ gene on adiposity, fat distribution and insulin sensitivity in Japanese men Biochem Biophys Res Commun 1998 251:: 195–198.
Ringel J, Engeli S, Distler A, Sharma A . Pro12Ala PPARγ2 missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus Biochem Biophys Res Communun 1999 254:: 450–453.
Mancini F, Vaccaro O, Sabatino L, Tufano A, Rivellese A, Riccardi G, Colantuoni V . Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes Diabetes 1999 48:: 1466–1468.
Beamer B, Yen C, Andersen R, Muller D, Elahi D, Cheskin L, Andres R, Roth J, Shuldiner A . Association of the Pro12Ala variant in the peroxisome proliferator activated receptor γ gene with obesity in two Caucasian populations Diabetes 1998 47:: 1806–1808.
Hercberg S, Preziosi P, Briançon S, Galan P, Triol I, Malvy D, Roussel A-M, Favier A . A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU-VI-MAX study-design, methods, and participants characteristics Controlled Clin Trials 1998 19:: 336–351.
Clément K, Lahlou N, Ruiz J, Hager J, Bougères P, Basdevant A, Guy-Grand B, Froguel P . Association of poorly controlled diabetes with low serum leptin in morbid obesity Int J Obes 1997 21:: 556–561.
Clément K, Dina C, Basdevant A, Chastang N, Pelloux V, Lahlou N, Berlan M, Langin D, Guy-Grand B, Froguel P . A sib-pair analysis study of 15 candidate genes in French families with morbid obesity. Indication for linkage with islet 1 locus on chromosome 5q Diabetes 1999 48:: 398–402.
Acknowledgements
Informed consents were obtained for all subjects and the protocols were approved by the Ethics Committee of Paris (CCPPRB Hôtel-Dieu and Cochin). This work was supported by the Direction de la Recherche Clinique/Assistance Publique-Hopitaux de Paris, Programme Hospitalier de Recherche Clinique (PHRC no. AOM 96088) and the Danone Institute (Danone/Suvimax DNA Bank). We thank Genevieve Bonhomme and Annie Legal for their excellent technical help. We also thank M. Ristow who kindly provided a mutated PPARγ2 cDNA plasmid
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clement, K., Hercberg, S., Passinge, B. et al. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes 24, 391–393 (2000). https://doi.org/10.1038/sj.ijo.0801191
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801191
Keywords
This article is cited by
-
PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine
Current Diabetes Reports (2021)
-
PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis
Scientific Reports (2020)
-
The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population
Endocrine (2015)
-
Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis
Molecular Biology Reports (2015)
-
PPAR α and PPAR γ Polymorphisms as risk factors for Dyslipidemia in a Chinese han population
Lipids in Health and Disease (2014)